da-refusal-vs-diluted-result

A DOT diluted drug test result is interpreted by classifying it as either negative-dilute or positive-dilute to determine FMCSA Part 40 compliance actions. This classification dictates whether a retest is required or if a violation process must begin.

A refusal in DOT drug testing involves failing to provide a specimen or obstructing collection, while an adulterated specimen indicates tampering. Both require specific MRO decisions and Clearinghouse reporting for safety-sensitive driver compliance.

You must report a DOT drug test refusal to the Clearinghouse when an MRO determines a safety-sensitive driver did not comply with testing protocols. This action fulfills FMCSA Part 40 reporting requirements for motor carrier drug programs.

An MRO decision confirming a positive drug test triggers immediate driver removal from safety-sensitive duties. Motor carriers must follow FMCSA Part 40 protocols to ensure compliance until return-to-duty processes are completed.

A negative-dilute DOT drug test result generally requires no further action unless specifically directed by the MRO. Compliance guidance maps these outcomes to FMCSA Part 40 regulations to confirm whether a retest is necessary.

A cancelled DOT drug test result requires no violation processing but typically necessitates a retest to fulfill FMCSA Part 40 requirements. This ensures accurate compliance tracking for safety-sensitive drivers.